APA (7th ed.) Citation

Zugck, C., Kell, R., Kirschke, A. E., Schellberg, D., Loßnitzer, D., Haass, M., & Haunstetter, A. (2001). Do we have to reassess classical risk predictors in patients with congestive heart failure since initiation of β-blocker treatment? European heart journal, 22, . https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1

Chicago Style (17th ed.) Citation

Zugck, Christian, Robert Kell, Andreas Erich Kirschke, Dieter Schellberg, Dirk Loßnitzer, Markus Haass, and Armin Haunstetter. "Do We Have to Reassess Classical Risk Predictors in Patients with Congestive Heart Failure Since Initiation of β-blocker Treatment?" European Heart Journal 22 (2001). https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1.

MLA (9th ed.) Citation

Zugck, Christian, et al. "Do We Have to Reassess Classical Risk Predictors in Patients with Congestive Heart Failure Since Initiation of β-blocker Treatment?" European Heart Journal, vol. 22, 2001, https://doi.org/10.1093/eurheartj/22.Abstract_Supplement.1.